Annual report pursuant to Section 13 and 15(d)

Condensed Parent Company Statements of Cash Flows (Detail)

v3.20.4
Condensed Parent Company Statements of Cash Flows (Detail) - USD ($)
$ in Thousands
3 Months Ended 12 Months Ended
Dec. 31, 2020
Sep. 30, 2020
[1]
Jun. 30, 2020
[1]
Mar. 31, 2020
Dec. 31, 2019
Sep. 30, 2019
Jun. 30, 2019
Mar. 31, 2019
Dec. 31, 2020
Dec. 31, 2019
Dec. 31, 2018
Operating Activities                      
Net income (loss) $ (239,674) [1] $ (148,036) $ (170,816) $ (59,422) [1] $ 26,839 $ 31,955 $ 101,861 $ 33,193 $ (617,948) [1] $ 193,848 $ 215,305
Adjustments to reconcile net income (loss) to cash provided by operating activities:                      
Share based awards compensation expense                 19,404 14,615 14,336
Equity in (income) loss of subsidiaries                 38,745 (41,870) (39,242)
Net cash provided by (used for) operating activities                 (330,098) 561,995 556,915
Investing Activities                      
Net cash used for investing activities                 (83,366) (310,642) (451,370)
Financing Activities                      
Dividends paid to stockholders                 (42,311) (159,281) (149,492)
Proceeds from convertible notes issued                 460,000    
Payment of debt issue costs                 (24,981)   (5,218)
Proceeds from warrants issued                 89,424    
Payroll taxes paid as a result of noncash stock option exercises                 (5,437) (2,308) (2,905)
Net cash provided by (used for) financing activities                 584,408 (186,506) (192,648)
Increase (decrease) in cash and cash equivalents                 167,025 62,091 (96,325)
Cash and cash equivalents:                      
Beginning of period       488,313       426,222 488,313 426,222 522,547
End of period 655,338       488,313       655,338 488,313 426,222
Convertible Notes                      
Financing Activities                      
Purchase of convertible note hedges                 (142,094)    
Cinemark Holdings, Inc.                      
Operating Activities                      
Net income (loss)                 (616,828) 191,386 213,827
Adjustments to reconcile net income (loss) to cash provided by operating activities:                      
Share based awards compensation expense                 919 920 920
Equity in (income) loss of subsidiaries                 606,168 (193,313) (215,735)
Changes in other assets and liabilities                 19,984 4,237 4,509
Net cash provided by (used for) operating activities                 10,243 3,230 3,521
Investing Activities                      
Dividends received from subsidiaries                 42,000 158,450 148,750
Net cash used for investing activities                 42,000 158,450 148,750
Financing Activities                      
Dividends paid to stockholders                 (42,311) (159,281) (149,492)
Proceeds from convertible notes issued                 460,000    
Payment of debt issue costs                 (17,122)    
Proceeds from warrants issued                 89,424    
Payroll taxes paid as a result of noncash stock option exercises                 (5,437) (2,308) (2,905)
Net cash provided by (used for) financing activities                 342,460 (161,589) (152,397)
Increase (decrease) in cash and cash equivalents                 394,703 91 (126)
Cash and cash equivalents:                      
Beginning of period       $ 97       $ 6 97 6 132
End of period $ 394,800       $ 97       394,800 $ 97 $ 6
Cinemark Holdings, Inc. | Convertible Notes                      
Financing Activities                      
Purchase of convertible note hedges                 $ (142,094)    
[1] Quarterly results during the year ended December 31, 2020 were impacted by the COVID-19 pandemic (see Note 3) as well as impairment recorded (see Notes 1 and 11).